Home > Insider Trading > Filing (0001140361-22-001654)

Filing Details

Accession Number:: 0001140361-22-001654
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-01-13 21:05:23
Reporting Period:: 2022-01-11

Accepted Time:: 2022-01-13 21:05:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1658551	Amylyx Pharmaceuticals Inc.	AMLX	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1103804	Viking Global Investors Lp	55 Railroad Avenue Greenwich CT 06830	No	No	No	No
1133006	Andreas Ole Halvorsen	C/O Viking Global Investors Lp 280 Park Ave 35Th New York NY 10017	No	No	No	No
1621842	C. David Ott	C/O Viking Global Investors Lp 280 Park Ave 35Th New York NY 10017	No	No	No	No
1629472	Viking Global Opportunities Portfolio Gp Llc	55 Railroad Avenue Greenwich CT 06830	No	No	No	No
1629476	Viking Global Opportunities Gp Llc	55 Railroad Avenue Greenwich CT 06830	No	No	No	No
1629482	Viking Global Opportunities Illiquid Investments Sub-Master Lp	Morgan Stanley Services (Cayman) Cricket Sq., Hutchins Dr., P.o. Box 2681 Grand Cayman E9 KY1-1111	No	No	No	No
1711393	Sharon Rose Shabet	C/O Viking Global Investors Lp 280 Park Ave 35Th New York NY 10017	No	No	No	No
1886738	Viking Global Opportunities Parent Gp Llc	55 Railroad Avenue Greenwich CT 06830	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-01-11	4,870,536	$0.00	4,870,536	No	4	C	Indirect	See Explanation of Responses
Common Stock	Acquisiton	2022-01-11	2,300,000	$19.00	2,300,000	No	4	P	Indirect	See Explanation of Responses

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Explanation of Responses
No	4	P	Indirect	See Explanation of Responses

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C-1 Preferred Stock	Disposition	2022-11-11	4,870,536	$0.00	4,870,536	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP ("VGI") and Viking Global Opportunities Parent GP LLC ("Parent"), which is the sole member of Viking Global Opportunities GP LLC ("Opportunities GP"), which is the sole member of Viking Global Opportunities Portfolio GP LLC ("Opportunities Portfolio GP"). VGI provides managerial services to various investment funds and vehicles, including Viking Global Opportunities Illiquid Investments Sub-Master LP ("Opportunities Fund") and DRAGSA 96 LLC ("DRAGSA 96"). Each of VGI, Parent, Opportunities GP, Mr. Halvorsen, Mr. Ott and Ms. Shabet (collectively the "Reporting Persons") may be deemed to beneficially own all of the securities reported on this form.
These shares are held directly by Opportunities Fund. Because of the relationship between VGI and Opportunities Fund, VGI may be deemed to beneficially own the shares held directly by Opportunities Fund.
Opportunities Portfolio GP is the general partner of Opportunities Fund. Because of the relationship between Parent, Opportunities GP, Opportunities Portfolio GP and Opportunities Fund, each of Parent, Opportunities GP and Opportunities Portfolio GP may be deemed to beneficially own the shares held directly by Opportunities Fund.
The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.
Each share of Series C-1 preferred stock was convertible on a one-for-one basis into Common Stock at any time at the election of the Reporting Persons and automatically converted upon the closing of the Issuer's initial public offering into the number of shares of the Issuer's Common Stock shown in column 3 of Table II without payment or further consideration. The Series C-1 Preferred stock had no expiration date.
These shares are held directly by DRAGSA 96. Because of the relationship between VGI and DRAGSA 96, VGI may be deemed to beneficially own the shares held directly by DRAGSA 96.
The membership interests of DRAGSA 96 are held by Viking Global Opportunities Intermediate LP and Viking Global Opportunities LP. Opportunities GP is the general partner of Viking Global Opportunities Intermediate LP and Viking Global Opportunities LP. Because of the relationship between Parent, Opportunities GP and DRAGSA 96, each of Parent and Opportunities GP may be deemed to beneficially own the shares of Common Stock held directly by DRAGSA 96.